GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Notes Receivable

Dannex Ayrton Starwin (XGHA:DASPHARMA) Notes Receivable : GHS0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Notes Receivable?

Dannex Ayrton Starwin's Notes Receivable for the quarter that ended in . 20 was GHS0.00 Mil.


Dannex Ayrton Starwin Notes Receivable Historical Data

The historical data trend for Dannex Ayrton Starwin's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Notes Receivable Chart

Dannex Ayrton Starwin Annual Data
Trend
Notes Receivable

Dannex Ayrton Starwin Semi-Annual Data
Notes Receivable

Dannex Ayrton Starwin Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Dannex Ayrton Starwin Notes Receivable Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines